Erythropoietin Resistance in Anemia of Chronic Kidney Disease
Official Title †
Novel Biomarkers of Erythropoietin Resistant Anemia Among Patients With Chronic Kidney Disease
Brief Summary
Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.
Detailed Description
Study Phase
Study Type †
Observational
Study Design †
Other, Other
Condition †
Anemia
Kidney Failure
Erythropoietin
Intervention †
Study Arms / Comparison Groups
Patients with CKD (estimated GFR < 60cc/min) not on hemodialysis who are receiving greater than or equal to 100IU/kg/week of epoetin alpha and/or
1mcg/kg/week darbepoetin to obtain target hemoglobin or hematocrit.
Patients with CKD (estimated GFR < 60cc/min) not on hemodialysis who are requiring <100IU/kg/week of epoetin alpha and/or 1mcg/kg/week of darbepoetin to obtain target hemoglobin/hematocrit.